Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Luis Martinez-Sobrido
Affiliation
Texas Biomedical Research Institute
ORCID
Career Start Year
2001
Papers
349
H Index
63
Expertise
CM4AI Collaborator
Kirsten Obernier (CM4AI)
PMID
Paper Title
Journal Title
Published Year
37990641
Extracellular Delivery of Functional Mitochondria Rescues the Dysfunction of CD4<sup>+</sup> T Cells in Aging.
Adv Sci (Weinh)
2024
34159337
Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effects.
bioRxiv
2023
37750714
Palmitoylethanolamide shows limited efficacy in controlling cerebral cryptococcosis <i>in vivo</i>.
Antimicrob Agents Chemother
2023
37515226
Fc-Effector-Independent in vivo Activity of a Potent Influenza B Neuraminidase Broadly Neutralizing Antibody.
Viruses
2023
37581931
Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effects.
J Clin Invest
2023
37651466
A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication in vivo.
PLoS Pathog
2023
37738983
Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis.
Cell Host Microbe
2023
37738970
SARS-CoV-2 variants evolve convergent strategies to remodel the host response.
Cell
2023
37090670
Palmitoylethanolamide shows limited efficacy in controlling cerebral cryptococcosis <i>in vivo</i>.
bioRxiv
2023
37191507
Immunization with Recombinant Accessory Protein-Deficient SARS-CoV-2 Protects against Lethal Challenge and Viral Transmission.
Microbiol Spectr
2023
37288969
A new tractable method for generating human alveolar macrophage-like cells <i>in vitro</i> to study lung inflammatory processes and diseases.
mBio
2023
37318331
Highly Cross-Reactive and Protective Influenza A Virus H3N2 Hemagglutinin- and Neuraminidase-Specific Human Monoclonal Antibodies.
Microbiol Spectr
2023
37187533
The IFN-stimulated gene IFI27 counteracts innate immune responses after viral infections by interfering with RIG-I signaling.
Front Microbiol
2023
36989354
Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors.
Sci Adv
2023
37345956
SARS-CoV-2 hijacks p38β/MAPK11 to promote virus replication.
mBio
2023
37115795
Glucuronoxylomannan intranasal challenge prior to Cryptococcus neoformans pulmonary infection enhances cerebral cryptococcosis in rodents.
PLoS Pathog
2023
37311533
Aerosolized sulfated hyaluronan derivatives prolong the survival of K18 ACE2 mice infected with a lethal dose of SARS-CoV-2.
Eur J Pharm Sci
2023
37278625
Identification of <i>In Vitro</i> Inhibitors of Monkeypox Replication.
Microbiol Spectr
2023
37243110
Vaccinia Virus Strain MVA Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Glycoprotein Induces Robust Protection and Prevents Brain Infection in Mouse and Hamster Models.
Vaccines (Basel)
2023
37131711
A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication and pathogenesis <i>in vivo</i>.
bioRxiv
2023
37131608
Antivirals against monkeypox infections.
bioRxiv
2023
37163142
Mitigation of SARS-CoV-2 by Using Transition Metal Nanozeolites and Quaternary Ammonium Compounds as Antiviral Agents in Suspensions and Soft Fabric Materials.
Int J Nanomedicine
2023
37066199
A new tractable method for generating Human Alveolar Macrophage Like cells in vitro to study lung inflammatory processes and diseases.
bioRxiv
2023
36656900
Clinical and pathological characterization of Central Nervous System cryptococcosis in an experimental mouse model of stereotaxic intracerebral infection.
PLoS Negl Trop Dis
2023
36786559
Phospholipase B Is Critical for Cryptococcus neoformans Survival in the Central Nervous System.
mBio
2023
36810517
Antibodies, B Cell Responses and Immune Responses to SARS-CoV-2 Infections.
Antibodies (Basel)
2023
36580912
SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming.
Cell
2023
36710070
Methamphetamine induces a low dopamine transporter expressing state without altering the total number of peripheral immune cells.
Basic Clin Pharmacol Toxicol
2023
36533953
Molecular Engineering of a Mammarenavirus with Unbreachable Attenuation.
J Virol
2023
36942851
Identification of a conserved S2 epitope present on spike proteins from all highly pathogenic coronaviruses.
Elife
2023
36894533
Circadian clock molecule REV-ERBα regulates lung fibrotic progression through collagen stabilization.
Nat Commun
2023
36793726
Interferon alpha inducible protein 6 is a negative regulator of innate immune responses by modulating RIG-I activation.
Front Immunol
2023
36698765
CoDe: a web-based tool for codon deoptimization.
Bioinform Adv
2023
36194133
SARS-CoV-2 3CL<sup>pro</sup> mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376.
Sci Transl Med
2023
34668775
The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
J Virol
2022
35738348
Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategies.
Antiviral Res
2022
35583364
Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine.
Microbiol Spectr
2022
35583360
Vaccinia Virus Attenuation by Codon Deoptimization of the A24R Gene for Vaccine Development.
Microbiol Spectr
2022
35821477
Generation, Characterization, and Applications of Influenza A Reporter Viruses.
Methods Mol Biol
2022
35821476
Bioluminescent and Fluorescent Reporter-Expressing Recombinant SARS-CoV-2.
Methods Mol Biol
2022
35821475
Generation of Bi-Reporter-Expressing Tri-Segmented Arenavirus.
Methods Mol Biol
2022
35817128
Dung biomass smoke exposure impairs resolution of inflammatory responses to influenza infection.
Toxicol Appl Pharmacol
2022
35862475
Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody.
PLoS Pathog
2022
35554912
Animal Models of COVID-19: Transgenic Mouse Model.
Methods Mol Biol
2022
35357221
Methamphetamine Enhances Cryptococcus neoformans Melanization, Antifungal Resistance, and Pathogenesis in a Murine Model of Drug Administration and Systemic Infection.
Infect Immun
2022
36342302
Use of a Bacterial Artificial Chromosome to Generate Recombinant SARS-CoV-2 Expressing Robust Levels of Reporter Genes.
Microbiol Spectr
2022
36146823
Molecular Analyses of Clinical Isolates and Recombinant SARS-CoV-2 Carrying B.1 and B.1.617.2 Spike Mutations Suggest a Potential Role of Non-Spike Mutations in Infection Kinetics.
Viruses
2022
36145467
Intranasal Immunization with Liposome-Displayed Receptor-Binding Domain Induces Mucosal Immunity and Protection against SARS-CoV-2.
Pathogens
2022
36106872
Respiratory Vaccination with Hemagglutinin Nanoliposomes Protects Mice from Homologous and Heterologous Strains of Influenza Virus.
J Virol
2022
35937688
Live attenuated influenza A virus vaccines with modified NS1 proteins for veterinary use.
Front Cell Infect Microbiol
2022
1 - 50 of 349
Column Actions
Search
Recommended Authors
James Logue
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year
2017
Number of shared co-authors
32
Thomas Vallet
Institut Pasteur, Center for the Viral Populations and Pathogenesis
Career Start Year
2017
Number of shared co-authors
30
Veronica V Rezelj
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Career Start Year
2015
Number of shared co-authors
38
David Sachs
Icahn School of Medicine at Mount Sinai
Career Start Year
2013
Number of shared co-authors
16
Brook E Heaton
Duke University School of Medicine
Career Start Year
2012
Number of shared co-authors
7
Hongjie Xia
University of Texas Medical Branch
Career Start Year
2012
Number of shared co-authors
4
Shashank Tripathi
Indian Institute of Science
Career Start Year
2011
Number of shared co-authors
32
Craig B Wilen
Yale School of Medicine
Career Start Year
2010
Number of shared co-authors
9
Xuping Xie
University of Texas Medical Branch
Career Start Year
2010
Number of shared co-authors
9
Jennifer Tisoncik-Go
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year
2009
Number of shared co-authors
9
Carles Mart??nez-Romero
Icahn School of Medicine at Mount Sinai
Career Start Year
2009
Number of shared co-authors
25
Vineet D Menachery
University of Texas Medical Branch
Career Start Year
2008
Number of shared co-authors
9
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year
2008
Number of shared co-authors
11
Alexander N Freiberg
University of Texas Medical Branch
Career Start Year
2008
Number of shared co-authors
11
Qiyun Zhu
Biodesign Center for Fundamental and Applied Microbiomics, Arizona State University
Career Start Year
2007
Number of shared co-authors
4
Nicholas S Heaton
Duke University School of Medicine
Career Start Year
2006
Number of shared co-authors
19
Mila B Ortigoza
NYU Grossman School of Medicine
Career Start Year
2006
Number of shared co-authors
9
Sudhakar Agnihothram
National Center for Toxicological Research
Career Start Year
2005
Number of shared co-authors
8
Alexandra Sch??fer
University of North Carolina at Chapel Hill
Career Start Year
2003
Number of shared co-authors
13
Satish K Pillai
Vitalant Research Institute, USA University of California san francisco
Career Start Year
2001
Number of shared co-authors
6
Amy C Sims
The University of North Carolina at Chapel Hill
Career Start Year
1998
Number of shared co-authors
7
Gary P Kobinger
University of Texas Medical Branch
Career Start Year
1997
Number of shared co-authors
15
Pei-Yong Shi
University of Texas Medical Branch
Career Start Year
1996
Number of shared co-authors
16
Larissa B Thackray
Washington University School of Medicine
Career Start Year
1996
Number of shared co-authors
9
Boyd L Yount
University of North Carolina at Chapel Hill
Career Start Year
1993
Number of shared co-authors
11
Lucy Thorne
University College London
Career Start Year
1992
Number of shared co-authors
29
James E Strong
University of Manitoba
Career Start Year
1991
Number of shared co-authors
7
Mark T Heise
University of North Carolina at Chapel Hill.
Career Start Year
1990
Number of shared co-authors
16
Bart L Haagmans
Erasmus Medical Center
Career Start Year
1986
Number of shared co-authors
12
Michael S Diamond
Washington University School of Medicine
Career Start Year
1982
Number of shared co-authors
31
row(s) 1 - 30 of 30
Collaborators
Chengjin Ye
Texas Biomedical Research Institute
Co-authored papers
51
Adolfo Garc??a-Sastre
Icahn School of Medicine at Mount Sinai
Co-authored papers
48
Arturo Casadevall
Johns Hopkins Bloomberg School of Public Health
Co-authored papers
19
Peter Palese
Icahn School of Medicine at Mount Sinai
Co-authored papers
8
Georg Kochs
Institute of Virology, Freiburg University Medical Center, University of Freiburg
Co-authored papers
7
Randy A Albrecht
Icahn School of Medicine at Mount Sinai
Co-authored papers
6
Larry S Schlesinger
Texas Biomedical Research Institute
Co-authored papers
5
Alexander L Greninger
University of Washington Medical Center
Co-authored papers
5
Lisa Miorin
Icahn School of Medicine at Mount Sinai
Co-authored papers
5
Martin S Zand
University of Rochester Medical Center
Co-authored papers
5
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers
4
Raveen Rathnasinghe
Icahn School of Medicine at Mount Sinai New York
Co-authored papers
4
Leonardo Nimrichter
Co-authored papers
4
Kris M White
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers
4
Viviana Simon
Icahn School of Medicine at Mount Sinai
Co-authored papers
3
Alexander F Rosenberg
University of Alabama at Birmingham Birmingham
Co-authored papers
3
Reuben S Harris
University of Texas Health San Antonio
Co-authored papers
3
Christopher F Basler
Icahn School of Medicine at Mount Sinai
Co-authored papers
3
Michael Schotsaert
Icahn School of Medicine at Mount Sinai
Co-authored papers
3
Paul A Goepfert
Co-authored papers
3
Shirit Einav
Stanford University School of Medicine
Co-authored papers
3
Netty Santoso
The Ohio State University Wexner Medical Center
Co-authored papers
3
Michael Gale
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers
3
Christopher B Wilson
Drukier Institute for Children's Health
Co-authored papers
3
Paul D De Jesus
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers
2
Sanjukta Bandyopadhyay
Co-authored papers
2
Richard Copin
Regeneron Pharmaceuticals
Co-authored papers
2
Galen J Correy
University of California san francisco
Co-authored papers
2
Rahul K Suryawanshi
Gladstone Institutes
Co-authored papers
2
Laura Martin-Sancho
The Scripps Research Institute
Co-authored papers
2
1 - 30